Skip Navigation


Annals of Oncology Advance Access originally published online on April 13, 2005
Annals of Oncology 2005 16(6):987; doi:10.1093/annonc/mdi177
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/6/987    most recent
mdi177v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dubernard, G.
Right arrow Articles by Delaloge, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubernard, G.
Right arrow Articles by Delaloge, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Safety of sentinel node biopsy in pregnant patients

The first 10% of the full text of this article appears below.

We read with interest the article entitled ‘Safety of sentinel node biopsy in pregnant patients with breast cancer’ by Gentilini et al. [1Go]. The authors sought to determine the safety of sentinel lymph node biopsy (SLN) in pregnant patients with breast cancer. Twenty-six . . . [Full Text of this Article]

G. Dubernard1,*, J. R. Garbay1, R. Rouzier1 and S. Delaloge2

1 Departments of Surgery, 2 Oncology, Institut Gustave Roussy, Villejuif, France

* Email: gil.dubernard@tnn.ap-hop-paris.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?